About
Modulo Bio develops drugs that reprogram microglial cells in the brain’s immune system to treat neurological diseases by combining stem cell engineering, multiomics, neurobiology, and machine learning.
Explore Modulo Bio's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.